Huakang Biomedical Holdings Co (HKSE:08622) Net Margin % : -47.92% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Huakang Biomedical Holdings Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Huakang Biomedical Holdings Co's Net Income for the three months ended in Dec. 2023 was HK$-3.59 Mil. Huakang Biomedical Holdings Co's Revenue for the three months ended in Dec. 2023 was HK$7.50 Mil. Therefore, Huakang Biomedical Holdings Co's net margin for the quarter that ended in Dec. 2023 was -47.92%.

The historical rank and industry rank for Huakang Biomedical Holdings Co's Net Margin % or its related term are showing as below:

HKSE:08622' s Net Margin % Range Over the Past 10 Years
Min: -52.93 Med: -7.35 Max: 40.78
Current: -23.37

HKSE:08622's Net Margin % is ranked worse than
74.34% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.06 vs HKSE:08622: -23.37

Huakang Biomedical Holdings Co Net Margin % Historical Data

The historical data trend for Huakang Biomedical Holdings Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huakang Biomedical Holdings Co Net Margin % Chart

Huakang Biomedical Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-1.11

-52.93

-16.15

-12.14

-23.48

Huakang Biomedical Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															-38.30	-8.91	-16.49	-16.52	-47.92

Competitive Comparison of Huakang Biomedical Holdings Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Huakang Biomedical Holdings Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huakang Biomedical Holdings Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huakang Biomedical Holdings Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Huakang Biomedical Holdings Co's Net Margin % falls into.

Huakang Biomedical Holdings Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Huakang Biomedical Holdings Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-6.324	/	26.939
	=	-23.48 %

Huakang Biomedical Holdings Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-3.593	/	7.498
	=	-47.92 %

Huakang Biomedical Holdings Co (HKSE:08622) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Huakang Biomedical Holdings Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Huakang Biomedical Holdings Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Huakang Biomedical Holdings Co (HKSE:08622) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huakang Biomedical Holdings Co Ltd (HKSE:08622) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.16 Yinkui Road, 1-3 floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN

Website

http://www.szhuakang.com

Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.

Executives

Tgga, Llc	2106 Person having a security interest in shares
Lau Lai Yee	2201 Interest of corporation controlled by you
Kokusai Resources Company Limited	2101 Beneficial owner
Zhang Shuguang	2101 Beneficial owner
Crystal Grant Limited	2101 Beneficial owner
Chang Yim Yang	2401 A concert party to an agreement to buy shares
Ever Charming Inc.	2101 Beneficial owner
Wealthy Pride Investment Limited	2101 Beneficial owner

Huakang Biomedical Holdings Co (HKSE:08622) Headlines

No Headlines